CLDI

Calidi Biotherapeutics Inc

$1.32

+0.02 (+1.54%)
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...

Analyst Overview

Target Price:
Date: 29.08.2026
$120.00
(+8990.91%)
Strong Buy: 0
Buy: 0
Hold: 0
Sell: 0
Strong Sell: 0
Description:
Calidi Biotherapeutics, Inc., a clinical stage immuno-oncology company, engages in developing immunotherapies for the treatment of cancer. The company is headquartered in San Diego, California.
Exchange:
AMEX
Country:
USA
Sector:
HEALTHCARE
Industry:
BIOTECHNOLOGY
Address:
4475 EXECUTIVE DRIVE, SAN DIEGO, CA, UNITED STATES, 92121
Fiscal year end:
December
Market capitalization:
$3.36 Million
EBITDA:
-$16.1 Million
PERatio:
0.0
EPS:
-37.04
Dividend per share:
$0.00
Dividend yield:
0.0%
Beta:
1.333

Dividends for 10 years

Loading...

Income Statements for 10 years

Loading...
Loading...

Income count if spend 1000$ ten years ago on shares

How much was you spent on shares:
$1,000
How much will you earn in 5 years:
-100%
How much will you get:
$0
Prices dates:
01-11-2021: $17,604.00 and 31-07-2026: $1.64